Please refer to the attachment.

Themis Medicare Ltd received an email from BSE seeking clarification regarding an increase in volume movement of its securities. In response, the company clarified that there is no pending or delayed disclosure of any material information as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The company affirmed that it regularly disseminates all required information and has no new material developments to report that would explain the volume change.